Integrative computational and in-vitro evidence implicates BCL2-associated apoptotic signaling in acetyl tributyl citrate-induced microglial toxicity.
Zou Songsong S, Li Lei L, Xiang Wenjun W, Li Yanglei Y et al.
Acetyl tributyl citrate (ATBC), a synthetic plasticizer, exhibits neurotoxic potential. Microglia sustain brain homeostasis, and their apoptosis and dysfunction are key drivers of Alzheimer's disease (AD) pathogenesis. However, the mechanism connecting ATBC exposure to microglial impairment and AD susceptibility remains unclear. Here, we applied an integrative computational and in-vitro framework to investigate BCL2-centered apoptotic signaling mediating ATBC-induced microglial toxicity. We retrieved ATBC targets from five prediction databases and AD-related genes from GeneCards and OMIM, obtaining 380 overlapping genes. Five hub genes (SRC, TNF, EGFR, BCL2, and ESR1) were screened via four centrality algorithms. Functional enrichment highlighted neurodegenerative disease pathways and microglia-related apoptotic cascades. We built 127 machine-learning models using two AD GEO cohorts (GSE122603, GSE97760). The robust Lasso + XGBoost ensemble (training AUC = 0.994) identified BCL2, SRC, ESR1, and EGFR as predictive features, with SHAP analysis pinpointing BCL2 as the top contributor. Molecular docking predicted favorable ATBC-BCL2 binding (-5.363 kcal/mol), and 100 ns molecular dynamics simulations supported stable complex formation. In BV2 microglia, ATBC dose-dependently reduced cell viability (IC50 = 59.59 μM), downregulated BCL2 expression, and activated caspase-dependent apoptosis. Collectively, our integrated evidence indicates that BCL2-associated apoptotic signaling mediates ATBC-provoked microglial toxicity, suggesting a plausible mechanistic link between ATBC exposure and AD-related signatures. This study proposes a microglia-oriented mechanistic hypothesis for AD susceptibility and offers a multi-omics paradigm for plasticizer risk assessment.